Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Deals

Acquisition of Babich-founded Noria helps Bayer pad radiopharmaceutical pipeline  

June 4, 2021 1:24 AM UTC

A deal unveiled Thursday will help Bayer expand its footprint in alpha-emitting targeted radiopharmaceuticals.

Bayer AG (Xetra:BAYN) announced it will acquire Noria Therapeutics Inc. and its subsidiary PSMA Therapeutics Inc., which have exclusive worldwide rights to targeted radiotherapy and diagnostic technology licensed from Weill Cornell Medicine and Johns Hopkins University, including an actinium 225-labeled, PSMA-targeting small molecule in preclinical development for prostate cancer. Financial details were not disclosed...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Bayer AG

Noria Therapeutics Inc.